The REGENERAR Project has been recognised by the European Commission’s Innovation Radar platform for delivering a series of Key Innovations in the field of brain regeneration.

In total, four innovations developed within the project were acknowledged, including one with very high market potential. All four contribute directly to Sustainable Development Goal 9: Build resilient infrastructure, promote inclusive and sustainable industrialization, and foster innovation.

This distinction underscores the commitment of the REGENERAR team to transforming cutting-edge research into impactful solutions for the treatment of neurological disorders.

Learn more about our innovations on the Innovation Radar platform:

• Non-viral delivery formulation for brain repair
• Polynucleotide construct for gene editing
• Purification process of dCas9 protein
• Toxicity testing of the non-viral delivery formulation for brain repair

By advancing innovations that enhance the brain’s ability to repair and regenerate, the project is paving the way toward more effective therapies and improved quality of life for patients.